Latest International Markets News

Perenti’s underground mining arm, Barminco, has won a significant three-year contract with Westgold Resources at the Great Fingall project, boosting its Australian mining portfolio and promising steady revenue growth.

Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

Kelsian’s Hotard Coaches has won a $59 million contract to provide workforce transportation for the Venture Global LNG CP2 project in Louisiana, marking a significant expansion in its US operations.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Cann Group Limited has received a $315,552 advance on its expected FY2025 Research and Development Tax Incentive, marking the second tranche of funding to support its ongoing cannabis medicine development.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Qantas Group is closing its Singapore-based low-cost carrier Jetstar Asia, recycling $500 million in capital to support fleet renewal and growth in Australia and New Zealand. The move impacts only 16 intra-Asia routes and aims to strengthen core markets amid rising costs and competition.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Austco Healthcare has completed its strategic acquisition of New Zealand’s G&S Technologies, enhancing its healthcare communication offerings and direct sales reach in the region.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.